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Ectopic pregnancy is a life threatening condition that
every obstetrician and gynecologist encounters in his or
her practice: therefore it is imperative to be familiar with
latest methods of treatment. Improved technology has
resulted in the diagnosis of ectopic pregnancy in
llnruptured stage thereby making less invasive treatment
and even medical management possible. This article
reviews the recent trends in the management ofectopic
pregnancy.
Various Treatment Options
Surgical: Salpingectomy or salpingotomy through
laparoscopy or laparotomy.
Medical: Administration ofcytotoxic drugs.
Surgical Treatment
Lawson Tait first described the life sav1l1g
procedure ofsalpingectomy in 1884 (1). Itwas not until
70 years later that less radical operations with
conservation of involved· tube were performed (2-4).
Laparoscopic methods were first used for the
management ofectopic pregnancy in 1980s (5,6). More
conservative and less invasive management is now
feasible as a result ofdevelopments in endoscopy (7).
Laparotomy versus Laparoscopy
The classical approach for ectopic pregnancy is by
open laparotomy. The laparoscopic treatmentofectopic
pregnancy will depend on patients' physical condition.
location, size and stateofectopic pregnancy, experience
ofsurgeon and availabilityofequipment. The advantages
of laparoscopic surgery are short hospital stay, quick
return to normal routine, few post operative analgesic
requirement and reduced cost (8-11). Murphy et al (12)
reported no significant difference in the operation time
between laparoscopy and laparotomy. However, the
patients treated by laparoscopy had reduction in
intraoperative blood loss and post-operative hospital
stay. A prospective study by Yao and Tulandi (II')
showed that intrauterine pregnancy rate was 70%
after laparoscopic surgery compared to 55% after
laparotomy. The recurrent ectopic pregnancy rate was
.also lowerafter laparoscopy (5%) than after laparotomy
(16.6%). However there was higher rate of persistent
trophoblastic tissue following laparoscopic approach
(12.2%) as compared to laparotomy(1.7%). Therefore
weekly HCG levels should be done following
conservative surgery(13). Persistent or rising levels of
HCG require surgical or medical treatment.
Haemodynamic instability is an absolute contraindication
to laparscopy. The other contraindications include
extensive pelvic adhesions. extensive haemoperitoneum
and obesity, which are dependent on operator skill and
experience (13,14).
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In a follow up study, development ofadhesions was
significantly less following laparoscopythan laparotomy
(1'>0.000I) (15).
Salpingectomy vel'sns salpingotomy
All tubal pregnanciescan betreated bysalpingectomy.
However, in patients who wish to conserve fertility and
who are haemodynamically stable with unruptured,
pregnancy (size of Scm), and absent or damaged
contralateral tube. conservative surgery in the form of
salpingotomy may be more suitable. Studies on fertility
after radical or conservative surgery have shown no
differenee in intrauterinepregnancyorectopicpregnancy
rates (11,16). Incidence ofpersistent ectopic was more
after salpingotomy (4.8-11 %) in contrast to no case
following salpingectomy (17-20)
A persistent trophoblast does not necessarily require
further surgery and in sOme cases may be managed by
medical treatment (21-24).
A single randomized trial investigated the effect of
slituring the salpingotomy incision (25) Intrauterine
pregnancy rate at 12 months was higher in those without
surgical repair but by24 months the rates with orwithout
suture were similar. Therefore it has been observed that
suturingthe tubeafter salpingotomy provides no benefit.
Medical Treatment
Early diagnosis has made medical treatment possible
for women with unruptured ectopic pregnancy (13,14)
thus avoiding surgery altogether. It is particularly
indicated in a haemodynamically stable reliable and
complaint patient with ectopic pregnancy definitely
within tube measuring <3.5 ellls with no evidence of
rupture (14.26). HCG greater than 10,000 lUll and fetal
cardiac activity are relative contraindicalions.
Methotrexate has been used successfully in Japan and
USA. Methotrexate is an anti-folate which prevents the
to
growthofrapidly dividingcells by interfering with DNA
synthesis. It has also been successfully used in the
treatment of gestational trophoblastic disease for
nearly four decades. It has also been used to promote
early resorption of placental tissues in abdominal
ectopic pregnancy. The successful resolution of a
tubal pregilancy with methotrexate was first described
in 1982 by Tanka et al (27). Methotrexate can be
administrated locally by laparoseopy or under ultrasound
guidanceor systemically. The two most commonly used
regImens are:
(a) Multidose administration
The multidose regimen was described in 1991.
Methotrexate is administered intramuscularlyat thedose
of Imglkgfollowed by leucovorin O.lmglkg24 hrs later.
One injection is given daily. This regimen is continued
until HCG levels decrease by 15%. On two consecuti,e
days, upto four doses can be given. but not all patients
require four doses.
(b) Single dose administration
The other commonly used regimen is single dose
methotrexate. Dose of SOmglm'ofbody surface area is
used without folinic acid rescue. Stovell and Ling (28)
reported that in a prospective study of 120 WOmen II ith
ectopic pregnancy, <3.5 CIll in greatest dimension. 113
women had successful resolution ofpregnancy. Thedose
of methotrexate was repeated if the serulll HCG Ie,els
failed to fall below 15% between day 4 and 7. A repeat
injectionofmethotrexate \\as required in4 (3.30/0) cases,
Tubal patency was delllonstrated on ipsilateral side ill
5 I of 62 (82.3%) patients. The subscquent fertility
experience after different regimens is difficult 10
summate because of gross discrepancies betweel1
collection methods used in individual trials. In Vao and
Tulandi's reviews, 54% of those attempting pregnancy
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achieved an intrauterine pregnancy ([UP) and 7% had
future ectopic pregnancy. A sl ightly lower IUP rate of
48% were noted after local injection under USGguidance
as compared to 58% under laparoscopic control. The
overall success rate is 88% with single dose whereas it
is 93% with multidose.
Mcthotrexate is contraindicated if there is evidence
ofimmunocompromise, hepatic, renal orhaematological
d,sfunction. peptic ulcer disease. Women should be
screened with complete blood count, liverfunction tests
and renal function tests. If women have pulmonary
disease they should be screened with chest radiography.
Cases offatal illterstitial pneumonitis have been reponed
after methotrexate administration in patients with
underlying pulmonary disease.
Side Effects
The incidence is related to both dose and mode of
administration. The side effects include stomatitis,
alopecia, haematosalpinx, elevation of liver enzymes.
V1ultiple O\arian cysts are reponed in 14.3% cases by
Ben-Scholomo et at (29). Late complications like
haematosalpinx and haematoceles presented with
abdominal pain, abnormal bleeding and pelvic mass 3-5
months after treatment (30). Failure oftherapy is more
likely to occur ifHCG levels are high (32% if levels>
10,000 IU compared to 3% if <I O,OOOIU), with large
tubal diameters (24% fai lure when ectopic pregnancy is
< 2 cms and 48% when diameter is > 2 cms) (31,32).
Side effects must bedistinguished from treatmenteffects
which include abdominal pain, an initial rise in HCG
levels and vaginal bleeding.
Methotrexate has been used to treat persistentectopic
pregnancy, cervical interstitial ovarian or abdominal
pregnancy. The chances ofsuccessful management can
be improved with adjuvant useoflocal injectionofKCL
with or without uterine a'1ery embolisation.
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Feto-maternal haemorrhage mayoccur in Rh-negative
women with Rh-positive fetus. It is thercfore
recommended that anti-D should be given in non-
sensitized mothers.
Conclusion
Ecotpic pregnancy IS a life threatening condition.
Though the incidence is showing increasing trend,
mortality is decreasing due to prompt diagnosis and
management. Traditional treatment is laparotomy
followed by salpingectomy or salpingotomy.
Laparoscopic treatment is less invasive but needs
expertise. Unruptured ectopic pregnancy can be managed
by medical treatment. While newer treatment options
offer several benefits to patients and health care
providers, patients with ectopic pregnancy should be
counselled properlyand monitored carefully. The patients
should understand the possible risk and should have 24
hour access to emergency.
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